Actinium Pharmaceuticals (ATNM)

Actinium Pharmaceuticals (ATNM) Cash flow


Actinium Pharmaceuticals Cash Flow

ATNM's free cash flow for Q was $-11.15M. For the fiscal year, ATNM's free cash flow was decreased by $29.28M and operating cash flow was $-11.13M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -47.62M$ 8.64M$ -20.87M$ -21.62M$ -21.46M$ -20.57M
Investing Cash Flow
$ -169.00K$ -366.00K$ -133.00K$ -253.00K$ -64.00K$ -96.09K
Financing Cash Flow
$ 18.57M$ 23.11M$ 35.22M$ 76.18M$ 17.11M$ 16.98M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 367.52M$ 109.61M$ 78.22M$ 64.00M$ 9.69M$ 14.10M
Income Tax Paid Supplemental Data
---$ 0.00$ 0.00$ 0.00
Interest Paid Supplemental Data
---$ 8.00K$ 26.00K$ 0.00
Issuance Of Capital Stock
$ 13.42M-$ 35.30M$ 76.59M$ 15.93M$ 16.98M
Issuance Of Debt
$ -4.00K$ -49.00K$ -85.00K---
Repayment Of Debt
$ -4.00K$ -49.00K$ -85.00K$ -460.00K$ -322.00K$ 0.00
Free Cash Flow
$ -47.79M$ 8.28M$ -21.00M$ -21.87M$ -21.53M$ -20.67M
Domestic Sales
Foreign Sales
Currency in USD

Actinium Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis